Stock · SYNGENE · Healthcare
SYNGENE share price target 2026
Support, resistance, the F&O structure and the BazaarBaazi Crack Score for SYNGENE INTERNATIONAL LIMITED, refreshed every end-of-day run. A systematic, data-only read on SYNGENE INTERNATIONAL LIMITED: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.
The verdict
BazaarBaazi reads SYNGENE as cautious with a Crack Score of 55/100 as of 25 Jul 2026.
BazaarBaaziSource & method
The scanner's readNear-perfect · scanned 24 Jul 2026
Where SYNGENE stands on the 500-name BazaarBaazi setup scanner: technicals, filed fundamentals and money flow read together, refreshed every run.
One directional side cleared its price-structure, filed-evidence and signed money-flow gates with no blocking red flag.
Technical axis
100/100Fundamental axis
50/100Money flow
22/100Result pulse · Q4 FY26
48/100Named setups in force
- stage4 downtrend
- breakdown 52w low
- under distribution
- RS laggard
- earnings deterioration
Technical evidence
price below 50DMA
price below 150DMA
price below 200DMA
50 < 150 < 200 DMA (bear stack)
at/near 52w low (<=4% above)
RSI 30.4 (weak)
below a bearish MA frame
not more than 5 ATR below 50DMA
money-flow score 21.5/100 (weak)
Chaikin money flow -0.292 (distribution)
net -5 accumulation days (25d)
OBV falling
RS slope -6.8% (3m)
RS line well below its high
relative strength falling vs NIFTY
below 50DMA
Fundamental evidence
net profit -19.31% YoY
result score 48.0/100 (weak)
YoY growth not accelerating
Valuation and context
P/E 51.2 vs sector median 49.5 (1.03x, 53th pctile)
P/E 0.93x its own ~15m median (54.9)
Relative valuation
P/E (TTM)
51.2P/E vs sector
+1.0%Sector percentile
53PEG
n/aGrowth gap
-48.9%P/E vs own history
+0.9%The engine's trade frame
Entry zone
403.3Stop
425.6Target 1
358.5Target 2
336.2Risk / reward
5.5% risk · 2.0RScanner levels from the deterministic engine run of 2026-07-24, not a SEBI-registered recommendation and not investment advice. The fundamental axis reads the official filing: Q4 FY26 result.
Price target: support and resistanceComputed 25 Jul 2026
Support and resistance for SYNGENE are read inside the latest show; no spot was printed in the most recent editorial note.
Levels are read inside the latest show. The most recent editorial reference is Systematic Read on 21 Jul 2026.
These are structural reference lines, not a SEBI-registered price target. BazaarBaazi is independent media; the levels frame how the desk reads the SYNGENE chart, refreshed every end-of-day run.
The Crack Score, and how it is built55 / 100 · Constructive
The Crack Score is a deterministic 0 to 100 conviction number. Here is exactly what moved it for SYNGENE, so the figure is a transparent signal rather than a vibe.
Base 50, adjusted by the factors above and clamped to 0 to 100. How the Crack Score works.
The F&O viewHorizon · swing
How the futures and options structure on SYNGENE reads right now.
The editorial price read on SYNGENE is bearish. Strike-level option inventory is unavailable, so the page withholds writer, wall and pin claims. Single-stock F&O on SYNGENE can be thinner than index F&O, so the desk weights price and filed evidence over raw OI. This is not a derivatives trade recommendation.
Why it movedLatest editorial line
The most recent BazaarBaazi read on what is driving SYNGENE.
Systematic read: a disclosed, data-only model on real 1-year price structure.
Read in Systematic Read on 21 Jul 2026. Why SYNGENE moved, the living explainer, tracks every move on one URL.
Latest filed resultsQ4 FY26
SYNGENE INTERNATIONAL LIMITED's most recent quarter, parsed straight from the official NSE filing. Every figure links back to its primary source.
Result Pulse
48 / 100Revenue
Rs 1,037 crNet profit
Rs 148 crEPS (quarter)
Rs 3.68| Growth | YoY | QoQ |
|---|---|---|
| Revenue | +1.8% | +13.0% |
| Net profit | -19.3% | +886.0% |
| Net margin | +14.3% | |
Figures are the Q4 FY26 result for SYNGENE INTERNATIONAL LIMITED, parsed straight from the official NSE integrated filing and verified to the paisa. The EPS shown is for the quarter, not a trailing-twelve-month figure, so it is not a P/E input.
Earnings history, every filed quarter32 quarters on record
SYNGENE INTERNATIONAL LIMITED's official quarterly revenue, EPS and Result Pulse trail, every quarter the desk holds from the verified filings export, back to 30 Jun 2018. These are quarterly facts, not TTM valuation inputs.
SYNGENE official result trail
32 quarters
Quarterly figures only: revenue, net profit and EPS are copied from official filings. EPS here is not trailing twelve month EPS and is not used for valuation.
| Quarter | Revenue | EPS | PAT YoY | Pulse | Source |
|---|---|---|---|---|---|
| Q4 FY26ended 31 Mar 2026 / Consolidated, audited | Rs 1,037 cr | Rs 3.68 | n/a | n/a | Filing |
| Q3 FY26ended 31 Dec 2025 / Consolidated, audited | Rs 917 cr | Rs 0.37 | n/a | 40/100 | Filing |
| Q2 FY26ended 30 Sep 2025 / Consolidated, audited | Rs 911 cr | Rs 1.67 | n/a | n/a | Filing |
| Q1 FY26ended 30 Jun 2025 / Consolidated, audited | Rs 875 cr | Rs 2.16 | n/a | n/a | Filing |
| Q4 FY25ended 31 Mar 2025 / Consolidated, audited | Rs 1,018 cr | Rs 4.56 | n/a | 58/100 | Filing |
| Q3 FY25ended 31 Dec 2024 / Consolidated, audited | Rs 944 cr | Rs 3.27 | n/a | n/a | Filing |
| Q2 FY25ended 30 Sep 2024 / Consolidated, audited | Rs 891 cr | Rs 2.64 | n/a | n/a | Filing |
| Q1 FY25ended 30 Jun 2024 / Consolidated, audited | Rs 790 cr | Rs 1.89 | n/a | n/a | Filing |
| Q4 FY24ended 31 Mar 2024 / Consolidated, audited | Rs 917 cr | Rs 4.70 | n/a | n/a | Filing |
| Q3 FY24ended 31 Dec 2023 / Consolidated, audited | Rs 854 cr | Rs 2.78 | n/a | n/a | Filing |
| Q2 FY24ended 30 Sep 2023 / Consolidated, audited | Rs 910 cr | Rs 2.90 | n/a | n/a | Filing |
| Q1 FY24ended 30 Jun 2023 / Consolidated, audited | Rs 808 cr | Rs 2.33 | n/a | n/a | Filing |
| Q4 FY23ended 31 Mar 2023 / Consolidated, audited | Rs 994 cr | Rs 4.46 | n/a | n/a | Filing |
| Q3 FY23ended 31 Dec 2022 / Consolidated, audited | Rs 786 cr | Rs 2.74 | n/a | n/a | Filing |
| Q2 FY23ended 30 Sep 2022 / Consolidated, audited | Rs 768 cr | Rs 2.55 | n/a | n/a | Filing |
| Q1 FY23ended 30 Jun 2022 / Consolidated, audited | Rs 645 cr | Rs 1.85 | n/a | n/a | Filing |
| Q4 FY22ended 31 Mar 2022 / Consolidated, audited | Rs 758 cr | Rs 3.71 | n/a | n/a | Filing |
| Q3 FY22ended 31 Dec 2021 / Consolidated, audited | Rs 641 cr | Rs 2.57 | n/a | n/a | Filing |
| Q2 FY22ended 30 Sep 2021 / Consolidated, audited | Rs 610 cr | Rs 1.64 | n/a | n/a | Filing |
| Q1 FY22ended 30 Jun 2021 / Consolidated, audited | Rs 595 cr | Rs 1.91 | n/a | n/a | Filing |
| Q4 FY21ended 31 Mar 2021 / Consolidated, audited | Rs 659 cr | Rs 4.04 | n/a | n/a | Filing |
| Q3 FY21ended 31 Dec 2020 / Consolidated, audited | Rs 585 cr | Rs 2.57 | n/a | n/a | Filing |
| Q2 FY21ended 30 Sep 2020 / Consolidated, audited | Rs 520 cr | Rs 2.12 | n/a | n/a | Filing |
| Q1 FY21ended 30 Jun 2020 / Consolidated, audited | Rs 422 cr | Rs 1.47 | n/a | n/a | Filing |
| Q4 FY20ended 31 Mar 2020 / Consolidated, audited | Rs 607 cr | Rs 3.03 | n/a | n/a | Filing |
| Q3 FY20ended 31 Dec 2019 / Consolidated, audited | Rs 519 cr | Rs 2.32 | n/a | n/a | Filing |
| Q2 FY20ended 30 Sep 2019 / Consolidated, audited | Rs 465 cr | Rs 3.23 | n/a | n/a | Filing |
| Q1 FY20ended 30 Jun 2019 / Consolidated, audited | Rs 421 cr | Rs 1.82 | n/a | n/a | Filing |
| Q4 FY19ended 31 Mar 2019 / Consolidated, audited | Rs 534 cr | Rs 5.05 | n/a | n/a | Filing |
| Q3 FY19ended 31 Dec 2018 / Consolidated, audited | Rs 467 cr | Rs 4.39 | n/a | n/a | Filing |
| Q2 FY19ended 30 Sep 2018 / Consolidated, audited | Rs 419 cr | Rs 3.96 | n/a | n/a | Filing |
| Q1 FY19ended 30 Jun 2018 / Consolidated, audited | Rs 406 cr | Rs 3.34 | n/a | n/a | Filing |
The official financialsFiled to 31 Mar 2026
SYNGENE INTERNATIONAL LIMITED's statements as filed: trailing twelve month P&L, the balance sheet, and the cash engine. Parsed from official XBRL, shown in crore.
Trailing twelve months, on filed quarters
Revenue (TTM)
3,739 crNet profit (TTM)
317 crEBIT (TTM)
460 crProfit before tax (TTM)
411 crNet margin (TTM)
8.5%Finance costs (TTM)
48.8 crBalance sheet, as filed 2026-03-31
Total assets
7,055 crShareholder equity
4,839 crTotal borrowings
9.4 crCash and equivalents
229 crInventory
141 crTrade receivables
509 crThe cash engine, latest filed year
Operating cash flow
915 crCapex
368 crFree cash flow
547 crInvesting flow
-860 crFinancing flow
-215 crAnnual trail, filed year over filed year
| Year | Revenue | Net profit | Equity | Borrowings | CFO |
|---|---|---|---|---|---|
| FY26 | 3,739 cr | 317 cr | 4,839 cr | 9.4 cr | 915 cr |
| FY25 | 3,642 cr | 496 cr | 4,727 cr | 120 cr | 1,168 cr |
| FY24 | 3,489 cr | 510 cr | 4,258 cr | 142 cr | 1,042 cr |
| FY23 | 3,193 cr | 464 cr | 3,618 cr | 575 cr | 824 cr |
| FY22 | 2,604 cr | 396 cr | 3,298 cr | 790 cr | 581 cr |
| FY21 | 2,184 cr | 405 cr | 2,821 cr | 772 cr | n/a |
Every figure is parsed from SYNGENE INTERNATIONAL LIMITED's official NSE XBRL filings by the BazaarBaazi earnings lab and shown in crore rupees. Display data, not a valuation model input.
Management on record29 earnings calls
Every SYNGENE earnings call BazaarBaazi has indexed, latest 30 Apr 2026. Read management in its own words, straight from the filed transcript.
SYNGENE INTERNATIONAL LIMITED earnings calls on record
29 calls since 30 Apr 2018
Show 21 older calls
Each entry links to the transcript PDF the company filed with the exchange. Primary sources, in management's own words.
What changed51 disclosures
Every recent official filing from SYNGENE INTERNATIONAL LIMITED, straight from the exchange feed, with the BazaarBaazi Event Heat on the disclosure flow.
SYNGENE INTERNATIONAL LIMITED has filed 51 official disclosures recently. The most recent is a Investor meet dated 22 Jul 2026.
Event Heat
21 / 100Certificate under SEBI (Depositories and Participants) Regulations, 2018
Resignation of M/s B S R & Co. LLP, Statutory Auditor of material subsidiary of the company w.e.f. July 07, 2026
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Intimation of Resignation letter of Mr. Peter Bains in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( SEBI Listing Regulations )
Event Heat is a dated net read of SYNGENE INTERNATIONAL LIMITED's last 90 days of official disclosures, balancing the constructive filings against the ones to watch. It is a signal from what the company has filed, not investment advice. Every line above links to its official exchange filing, and the full market desk is at the disclosures hub.
Key fundamentalsEditorial reference
The anchor data BazaarBaazi references when reading the SYNGENE chart. Not a substitute for a registered research note.
| Ticker | SYNGENE |
|---|---|
| Full name | SYNGENE INTERNATIONAL LIMITED |
| Sector | Healthcare |
| Index class | MID CAP |
| ISIN | INE398R01022 |
| Market-cap band | ~16,609 cr (indicative) |
| Last referenced level | Inside latest show |
| Last session move | Not referenced this cycle |
| Editorial line in | Systematic Read on 21 Jul 2026 |
| Aliases tracked | SYNGENE |
Reference chartLevels in show
The daily frame the desk reads on SYNGENE.
FAQ13 reader questions · AEO-eligible
The line on SYNGENE, distilled and schema-marked for AI Overview, Perplexity, and reader search.
What is the SYNGENE share price target for 2026?
BazaarBaazi does not publish a SEBI-registered price target on SYNGENE. The desk reads structural support and resistance inside each show against the printed spot; the most recent editorial line is Systematic Read on 21 Jul 2026.
What is BazaarBaazi's Crack Score for SYNGENE?
The BazaarBaazi Crack Score for SYNGENE is 55 out of 100 as of 25 Jul 2026, a constructive reading. It is a computed conviction number from the signed stance, how consistent the recent verdicts have been, the quality of the printed structure, and how fresh the review is. It is a transparency signal, not investment advice.
What is the F&O view on SYNGENE?
Strike-level option inventory for SYNGENE is unavailable, so BazaarBaazi withholds participant, direction and positioning claims. The editorial chart stance is not substituted for an option-chain observation.
What sector is SYNGENE in and which peers does BazaarBaazi track?
SYNGENE sits in Healthcare (mid cap), indicative market cap ~16,609 cr (indicative), ISIN INE398R01022. The peers BazaarBaazi reads alongside it are GLAND PHARMA LIMITED, Eris Lifesciences Limited, ACUTAAS CHEMICALS LIMITED. A systematic, data-only read on SYNGENE INTERNATIONAL LIMITED: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.
How often is the SYNGENE view updated?
This page is one evergreen URL refreshed in place. The Crack Score and levels re-compute on every BazaarBaazi end-of-day run, and the dated stamp shows the last refresh. The latest signed verdict on SYNGENE is bearish, published in Systematic Read on 21 Jul 2026.
Is SYNGENE a qualifying setup on the BazaarBaazi scanner right now?
On the 2026-07-24 run of the 500-name BazaarBaazi setup scanner, SYNGENE INTERNATIONAL LIMITED sits in the Near-perfect tier with a setup score of 82/100 (technical 100, fundamental 50). The scanner is a deterministic engine over real OHLCV and official filings, refreshed nightly, and it is a signal rather than investment advice.
Where can I read SYNGENE INTERNATIONAL LIMITED's earnings call transcripts?
BazaarBaazi indexes 29 SYNGENE earnings calls going back to 2018-04-30, latest 2026-04-30. Every entry on this page links straight to the transcript PDF the company filed with the exchange, so you read management in the primary source.
What was SYNGENE INTERNATIONAL LIMITED's Q4 FY26 net profit?
SYNGENE INTERNATIONAL LIMITED reported a net profit of Rs 148 cr for Q4 FY26 (the quarter ended 31 March 2026). That is -19.3% year on year. The figure is from the company's official NSE filing.
What was SYNGENE INTERNATIONAL LIMITED's Q4 FY26 revenue?
SYNGENE INTERNATIONAL LIMITED reported revenue of Rs 1,037 cr for Q4 FY26. That is +1.8% year on year. The figure is from the company's official NSE filing.
How does BazaarBaazi rate SYNGENE INTERNATIONAL LIMITED's Q4 FY26 result?
BazaarBaazi gives SYNGENE INTERNATIONAL LIMITED's Q4 FY26 result a Result Pulse of 48 out of 100, with a verdict of Mixed. The Result Pulse is a BazaarBaazi editorial score for the quality of the filed result, not investment advice.
What has Syngene International Ltd announced recently?
Syngene International Ltd's two most material recent disclosures are an investor meet dated 22 Jul 2026, "Schedule of meet", and a disclosure dated 14 Jul 2026, "change in Management". Both link to the company's own official filing on the BazaarBaazi stock page.
Has Syngene International Ltd declared a dividend recently?
Yes. Syngene International Ltd filed a dividend disclosure on 25 Jun 2026, filed as "Dividend - Rs 1.25 Per Share". Any amount shown is the exchange's own record, linked from the BazaarBaazi stock page. A dividend is a declared payout, not a forecast of future returns.
What did Syngene International Ltd's latest board meeting cover?
Syngene International Ltd's most recent board-meeting disclosure on record dated 02 Jul 2026 reads "Notice of Annual General Meeting to be held on July 29, 2026". That is the agenda as filed with the exchange, linked from the BazaarBaazi stock page, and BazaarBaazi adds no claim of its own to it.
Related stock views
The names BazaarBaazi reads alongside SYNGENE, each a living view refreshed every end-of-day run.